If you need more lookups,
subscriptions start at $34 USD/month.
Ben Toogood Location
United Kingdom
Ben Toogood Work
2025 -now Board Member @
2021 -now Chief Executive Officer @
2021 -now Board Member @
2021 -2024 Board Member @
2016 -2020 Head Global BD and M and A Sandoz @
2013 -2016 Group New Business Development Executive @
2006 -2013 Vice President Of Global Business Development @
2004 -2006 Business Development @
2002 -2004 Regulatory Affairs @ Merck Generics
1998 -2001 Pharmaceutical Manufacture @ Pharma Natura
Ben Toogood Education
University of Cambridge
Executive MBA (Management)
2010-2012
Rhodes University
BPharm
1993-1998
University of the Witwatersrand
MSc
Cardiff University / Prifysgol Caerdydd
(Diploma in Regulatory Affairs)
Ben Toogood Skills
Pharmaceutical Industry
Regulatory Affairs
Lifesciences
Technology Transfer
Biotechnology
Generic Programming
21 CFR Part 11
Biopharmaceuticals
Business Development
Business Strategy
CRO
Clinical Development
Clinical Trials
Commercialization
Drug Discovery
Cross-functional Team Leadership
FDA
Formulation
GMP
New Business Development
Oncology
Pharmaceutical Sales
Pharmaceutics
Regulatory Requirements
Sales Effectiveness
Strategic Communications
Sales
Leadership
HTML
Project Management
Cross Functional Team Leadership
Ben Toogood Summary
Ben Toogood, based in United Kingdom, is currently a Chief Executive Officer at invoX Pharma Limited. Ben Toogood brings experience from previous roles at Jamjoom Pharma, Karolinska Development, pHion Therapeutics and Novartis. Ben Toogood holds a 2010 - 2012 Executive MBA in Management @ University of Cambridge. With a robust skill set that includes Pharmaceutical Industry, Regulatory Affairs, Lifesciences, Technology Transfer, Biotechnology and more. Ben Toogood has 4 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Ben Toogood?
Find contact details for 700 million professionals.